| 26/10/17 | 09:10:01 | 26 Oct 2017 | | Total Voting Rights | RNS |
| 23/10/17 | 08:00:03 | 23 Oct 2017 | | Parsortix harvests cancer cells from bone marrow | RNS |
| 20/10/17 | 16:05:29 | 20 Oct 2017 | | Notice of AGM | RNS |
| 17/10/17 | 08:00:06 | 17 Oct 2017 | | ANGLE: 7th Peer Reviewed Publication On Parsortix | RNS |
| 12/10/17 | 08:00:02 | 12 Oct 2017 | | Proposed further subscription for £2.8 million | RNS |
| 09/10/17 | 08:00:05 | 9 Oct 2017 | | Parsortix Showcased at CTC Conference | RNS |
| 05/10/17 | 12:46:06 | 5 Oct 2017 | | Results of Fundraising | RNS |
| 05/10/17 | 08:00:04 | 5 Oct 2017 | | Acquisition and Fundraising | RNS |
| 13/09/17 | 18:36:16 | 13 Sept 2017 | | Holding(s) in Company | RNS |
| 13/09/17 | 08:00:05 | 13 Sept 2017 | | Exclusive worldwide option over megakaryocyte IP | RNS |
| 11/09/17 | 08:00:04 | 11 Sept 2017 | | Co-Marketing Partnership with QIAGEN | RNS |
| 05/09/17 | 08:00:04 | 5 Sept 2017 | | Change of Adviser | RNS |
| 04/09/17 | 08:00:06 | 4 Sept 2017 | | New Research with Parsortix | RNS |
| 27/07/17 | 08:00:14 | 27 Jul 2017 | | Preliminary Results | RNS |
| 06/07/17 | 11:05:25 | 6 Jul 2017 | | Notice of Results | RNS |
| 04/07/17 | 08:00:03 | 4 Jul 2017 | | Successful Headline Data in Ovarian Cancer Studies | RNS |
| 15/06/17 | 08:00:05 | 15 Jun 2017 | | Parsortix breakthrough in prostate cancer | RNS |
| 05/06/17 | 08:00:05 | 5 Jun 2017 | | Success with Parsortix in Colorectal Cancer | RNS |
| 03/05/17 | 08:00:11 | 3 May 2017 | | Business Update | RNS |
| 04/04/17 | 08:00:11 | 4 Apr 2017 | | Holding(s) in Company | RNS |
| 03/04/17 | 08:00:09 | 3 Apr 2017 | | Parsortix enables analysis in head and neck cancer | RNS |
| 30/03/17 | 08:00:11 | 30 Mar 2017 | | Prostate Cancer Update | RNS |
| 13/02/17 | 07:00:09 | 13 Feb 2017 | | Selected for European Cancer ID Programme | RNS |
| 28/11/16 | 07:00:09 | 28 Nov 2016 | | ISSUE OF SHARE OPTIONS | RNS |
| 24/11/16 | 14:48:56 | 24 Nov 2016 | | Result of GM | RNS |
| 04/11/16 | 07:00:05 | 4 Nov 2016 | | Barts Research Supports Potential Use of Parsortix | RNS |
| 27/10/16 | 08:00:11 | 27 Oct 2016 | | Director's share purchase | RNS |
| 07/10/16 | 12:57:46 | 7 Oct 2016 | | Holding(s) in Company | RNS |
| 04/10/16 | 17:35:48 | 4 Oct 2016 | | Result of AGM | RNS |
| 30/09/16 | 08:00:09 | 30 Sept 2016 | | Research published in Clinical Chemistry | RNS |
| 19/09/16 | 12:14:48 | 19 Sept 2016 | | Issue of Equity | RNS |
| 09/09/16 | 17:12:55 | 9 Sept 2016 | | Annual Report and Accounts and Notice of AGM | RNS |
| 28/07/16 | 08:00:11 | 28 Jul 2016 | | Preliminary Results | RNS |
| 27/07/16 | 08:00:11 | 27 Jul 2016 | | Initiation of 200 patient US ovarian cancer study | RNS |
| 19/07/16 | 08:00:07 | 19 Jul 2016 | | Initiation of European ovarian cancer study | RNS |
| 15/07/16 | 08:00:06 | 15 Jul 2016 | | Notice of Results | RNS |
| 15/07/16 | 08:00:05 | 15 Jul 2016 | | Parsortix gaining traction at EACR Conference | RNS |
| 01/06/16 | 16:04:00 | 1 Jun 2016 | | Holding(s) in Company | RNS |
| 31/05/16 | 17:36:18 | 31 May 2016 | | Holding(s) in Company | RNS |
| 25/05/16 | 08:00:12 | 25 May 2016 | | Cancer Research UK Contract | RNS |
| 25/05/16 | 08:00:12 | 25 May 2016 | | Placing | RNS |
| 18/04/16 | 08:00:06 | 18 Apr 2016 | | Parsortix potential in metastatic breast cancer | RNS |
| 21/03/16 | 07:00:11 | 21 Mar 2016 | | Parsortix potential for prostate cancer detection | RNS |
| 09/03/16 | 07:00:09 | 9 Mar 2016 | | European patent grant for Parsortix | RNS |
| 28/01/16 | 07:00:08 | 28 Jan 2016 | | Interim Results | RNS |
| 27/01/16 | 10:42:59 | 27 Jan 2016 | | Notice of Interim Results | RNS |
| 25/01/16 | 07:00:10 | 25 Jan 2016 | | UKE publishes evaluation of Parsortix | RNS |
| 22/12/15 | 07:00:05 | 22 Dec 2015 | | Completion of Geomerics Transaction | RNS |
| 15/12/15 | 07:00:06 | 15 Dec 2015 | | Parsortix first commercial sales | RNS |
| 30/11/15 | 17:56:17 | 30 Nov 2015 | | Holding(s) in Company | RNS |
